Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000423

Type of data
NGS (scRNA-seq)
NGS (bulk RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
280 GB
File formats
  • FASTQ
  • CSV
Research
hum0147
Date published
2022-02-10
Date modified
2022-02-10
DDBJ Search
JGAD000423 (opens in a new tab)
JGA Study
JGAS000312 (opens in a new tab)

Analysis method

scRNA-seq

Materials and participants
1 healthy donor (STR5)
5 cancer patients
Bladder cancer (ICD10: C67), Colon cancer (ICD10: C20), Kidney cancer (ICD10: C64), Lung cancer (ICD10: C34.3), Ovarian cancer (ICD10: C56)
  • Health status
    Mixed
  • Subject count
    6 (Individual)
Disease
Bladder cancer (C67)
Colon cancer (C20)
Kidney cancer (C64)
Lung cancer (C343)
Ovarian cancer (C56)
Sample description
RNAs extracted from T cells of peripheral blood mononuclear cells from a healthy donor and tumor-infiltrating T cells from cancer patients
  • Tissue
    PBMC, Peripheral blood, TIL
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
scRNA-seq
Target
N/A
Reagent kit
BD Rhapsody Targeted mRNA Kit
Fragmentation
N/A
Platform
Illumina HiSeq 3000
Read type
Paired-end
Read length
100 bp
Data use policy
NBDC data sharing policy (JGAP000001)

bulk RNA-seq

Materials and participants
Kidney cancer (ICD10: C64): 2 cases
T cells of peripheral blood mononuclear cells: 6 fractions each
tumor-infiltrating T cells: 4 fractions each
Lung cancer (ICD10: C34): 3 cases
tumor-infiltrating T cells: 2 fractions each
  • Health status
    Affected
  • Subject count
    5 (Individual)
Disease
Kidney cancer (C64)
Lung cancer (C34)
Sample description
RNAs extracted from T cell fractions of peripheral blood mononuclear cells and tumor-infiltrating T cell fractions
  • Tissue
    PBMC, Peripheral blood, TIL
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
KAPA Hyper Prep Kit
Fragmentation
KAPA Frag
Platform
Illumina HiSeq 2500
Illumina HiSeq 4000
Read type
Paired-end
Read length
100 bp
Data use policy
NBDC data sharing policy (JGAP000001)